TRCT
EDVA

Tower Research Capital (TRC)’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$623 Hold
1,005
– – ﹤0.01% 4985
2026
Q1 		$1.44K Hold
1,005
– – ﹤0.01% 4661
2025
Q4 		$2.78K Buy
1,005
+401
+66% +$2.4K ﹤0.01% 4473
2025
Q3 		$5.7K Buy
+604
New +$5.26K ﹤0.01% 4209
2025
Q2 		– Sell
-239
Closed -$1.34K – 5534
2025
Q1 		$1.34K Buy
239
+151
+172% +$4.24K ﹤0.01% 4730
2024
Q4 		$2.28K Sell
88
-54
-38% -$1.79K ﹤0.01% 4874
2024
Q3 		$5.74K Buy
142
+28
+25% +$1.41K ﹤0.01% 4228
2024
Q2 		$4.21K Buy
114
+6
+6% +$281 ﹤0.01% 4805
2024
Q1 		$7.96K Sell
108
-10
-8% -$797 ﹤0.01% 4107
2023
Q4 		$10.4K Buy
118
+95
+413% +$9.04K ﹤0.01% 4247
2023
Q3 		$2.21K Buy
23
+5
+28% +$648 ﹤0.01% 5196
2023
Q2 		$3.28K Sell
18
-57
-76% -$10.4K ﹤0.01% 5089
2023
Q1 		$20K Buy
75
+18
+32% +$3.57K ﹤0.01% 3443
2022
Q4 		$9K Sell
57
-41
-42% -$7.19K ﹤0.01% 4256
2022
Q3 		$21K Buy
98
+86
+717% +$32.6K ﹤0.01% 3902
2022
Q2 		$6K Sell
12
-43
-78% -$15.5K ﹤0.01% 4948
2022
Q1 		$25K Buy
55
+6
+12% +$3.06K ﹤0.01% 3336
2021
Q4 		$9K Buy
49
+48
+4,800% +$13K ﹤0.01% 4714
2021
Q3 		$0 Hold
1
– – ﹤0.01% 6120
2021
Q2 		$0 Buy
+1
New +$548 ﹤0.01% 5790

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tower Research Capital (TRC)'s EDVA Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Endovia Health Sciences, Inc. (EDVA) position steady in Q2 2026 at 1,005 shares worth $623. The position accounts for ﹤0.01% of the portfolio, ranked #4985.

Tower Research Capital (TRC) first reported a position in EDVA in Q2 2021 and has held it in 20 quarters since. The position peaked at $25K in Q1 2022. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Tower Research Capital (TRC) held 1,005 shares of Endovia Health Sciences, Inc. worth $623 as of Q2 2026.
  • Tower Research Capital (TRC) left its Endovia Health Sciences, Inc. share count unchanged in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4985 holding.
  • Tower Research Capital (TRC) first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Endovia Health Sciences, Inc. position peaked at $25K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.